Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Parthenon Therapeutics Raises $65M in Series A

2021-11-06
CAMBRIDGE, MA, Parthenon Therapeutics announced a $65 million Series A financing led by Northpond Ventures, Pfizer Ventures, and Taiho Ventures.
Parthenon Therapeutics, a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment, announced a $65 million Series A financing led by Northpond Ventures, Pfizer Ventures, and Taiho Ventures.

Additional investors included Section 32, Breakout Ventures, funds managed by Tekla Capital Management LLC, Creacion Ventures, KdT Ventures, Park West Asset Management LLC, and Alexandria Venture Investments.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors